Valuation: Futura Medical plc

Market Cap 2.15M 2.89M 2.52M 2.33M 4.08M 275M 4.15M 27.83M 10.93M 136M 10.84M 10.6M 466M P/E 2024
77.2x
P/E 2025 -0.4x
Enterprise Value -1.25M -1.68M -1.47M -1.35M -2.37M -160M -2.41M -16.18M -6.35M -78.86M -6.3M -6.16M -271M EV / Sales 2024
6,428,637x
EV / Sales 2025 1,815,433x
Free-Float
83.88%
Yield 2024 *
-
Yield 2025 -
1 day-7.50%
1 week-33.69%
Current month-28.85%
1 month-36.21%
3 months-68.29%
6 months-76.13%
Current year-66.82%
1 week 0.24
Extreme 0.244
0.55
1 month 0.24
Extreme 0.244
0.7
Current year 0.24
Extreme 0.244
1.75
1 year 0.24
Extreme 0.244
14.85
3 years 0.24
Extreme 0.244
61.5
5 years 0.24
Extreme 0.244
67
10 years 0.24
Extreme 0.244
95.6
Manager TitleAgeSince
Chief Executive Officer 56 2025-08-07
Director of Finance/CFO 46 2018-02-19
Chief Tech/Sci/R&D Officer 74 2016-11-15
Director TitleAgeSince
Director/Board Member 74 2016-03-31
Director/Board Member 46 2018-02-19
Chairman 69 -
Date Insider Type Main position Quantity % Market Cap.
12-07Buy

Chief Financial Officer

500,000 0.1488%
12-07Buy

Chief Executive Officer

5,000,000 1.4876%
12-07Buy

Chief Technology Officer

500,000 0.1488%
Change 5-day change 1-year change 3-year change Capi.($)
-7.50%-33.69%-96.88%-99.32% 2.89M
+1.84%-0.66%+59.82%+94.48% 54.88B
-4.14%-8.06%+58.96%+125.71% 54.63B
-2.24%+3.59%+17.75%+469.23% 25.06B
-1.60%-6.21%-18.96%-16.06% 23.14B
-1.79%-1.32%+39.44%-8.35% 19.87B
-3.19%0.00%+35.60%-27.49% 17.55B
-6.84%+2.18%+195.12%+364.56% 16.5B
-5.01%-6.32%+43.06%+615.91% 15.75B
-1.05%+1.16%+25.95%+191.69% 14.2B
Average -3.15%-3.62%+35.99%+171.03% 24.16B
Weighted average by Cap. -2.14%-1.45%+50.44%+170.66%

Financials

2024 2025
Net sales 13.93 18.69 16.35 15.08 26.42 1.78K 26.87 180.16 70.75 878.08 70.17 68.64 3.02K 1.7 2.28 1.99 1.84 3.22 217.16 3.27 21.95 8.62 106.98 8.55 8.36 367.77
Net income 1.29M 1.74M 1.52M 1.4M 2.45M 165M 2.49M 16.73M 6.57M 81.53M 6.52M 6.37M 280M -9.07M -12.17M -10.65M -9.82M -17.21M -1.16B -17.5M -117M -46.08M -572M -45.71M -44.71M -1.97B
Net Debt -6.6M -8.85M -7.74M -7.14M -12.52M -844M -12.73M -85.33M -33.51M -416M -33.24M -32.51M -1.43B -3.4M -4.56M -3.99M -3.68M -6.45M -435M -6.56M -44.01M -17.28M -214M -17.14M -16.77M -737M
Logo Futura Medical plc
Futura Medical plc is a consumer healthcare company that specializes in the development and global commercialization of sexual health products. The Company is a developer of sexual health products, including the lead product, Eroxon, and two products in development, including WSD4000 and Eroxon Intense. Eroxon is a clear gel used for the treatment of erectile dysfunction (ED) available over the counter and without prescription and addresses significant unmet needs in the ED market. Eroxon Intense provides a potential range extension of the Eroxon product and acts as an additional treatment option for men who have ED. WSD4000 is a topical treatment designed for sexual dysfunction in women. The Company has distribution partners in place in a number of major consumer markets, including Haleon in the United States, and Cooper Consumer Health in Europe.
Employees
13
Date Price Change Volume
26-07-10 GBX 0.3700 -7.50% 12,351,521
26-07-09 GBX 0.4000 0.00% 7,808,134
26-07-08 GBX 0.4000 0.00% 14,346,032
26-07-07 GBX 0.4000 -27.80% 7,041,893
26-07-06 GBX 0.5540 -0.72% 8,203,238

Annual profits - Rate of surprise